Not Cleared Direct

DEN200038 - Gili Pro BioSensor (also known as “Gili BioSensor System”) (FDA 510(k) Clearance)

Apr 2021
Decision
293d
Days
Class 2
Risk

DEN200038 is an FDA 510(k) submission for the Gili Pro BioSensor (also known as “Gili BioSensor System”). This device is classified as a Hardware And Software For Optical Camera-based Measurement Of Heart Rate And Respiratory Rate (Class II - Special Controls, product code QOK).

Submitted by Continuse Biometrics , Ltd. (Tel-Aviv, IL). The FDA issued a Not Cleared (DENG) decision on April 1, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2786. The Device Uses An Optical Sensor System And Software Algorithms To Obtain And Analyze Video Signal And Estimate Pulse Rate, Heart Rate, Respiratory Rate And/or Breathing Rates. This Device Is Not Intended To Independently Direct Therapy..

Submission Details

510(k) Number DEN200038 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received June 12, 2020
Decision Date April 01, 2021
Days to Decision 293 days
Submission Type Direct
Review Panel Cardiovascular (CV)
Summary -

Device Classification

Product Code QOK - Hardware And Software For Optical Camera-based Measurement Of Heart Rate And Respiratory Rate
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2786
Definition The Device Uses An Optical Sensor System And Software Algorithms To Obtain And Analyze Video Signal And Estimate Pulse Rate, Heart Rate, Respiratory Rate And/or Breathing Rates. This Device Is Not Intended To Independently Direct Therapy.